Status:
COMPLETED
Clinical and Neurophysiological Characteristics of Narcolepsy
Lead Sponsor:
I.M. Sechenov First Moscow State Medical University
Conditions:
Narcolepsy Type 1
Eligibility:
All Genders
7-78 years
Brief Summary
The study is the first attempt in post-Soviet Russian history to collect and analyze the existing available data of narcolepsy cohort in order to get prove characteristics of narcolepsy in Russia acco...
Detailed Description
First reports of narcolepsy with cataplexy in Russia were made by Mankovsky in 1925 (narcolepsy with cataplexy, NC). The largest series of patients (n=110) was reported by A. Vein in 1964. Narcolepsy ...
Eligibility Criteria
Inclusion
- Signed written informed consent of the patient and/or parent/adoptive parent (in the case of a minor) to participate in the study;
- Age: 6-80 years;
- Gender: Men and women;
- Established diagnosis: Narcolepsy of type I and II (according to the criteria of the International classification of sleep disorders of 2014).
Exclusion
- Refusal of the patient or his parent / adoptive parent (in the case of a minor) from further participation in the study;
- The occurrence of a serious illness or a significant deterioration of a disease unrelated to narcolepsy;
- Pregnancy started after inclusion.
Key Trial Info
Start Date :
November 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 28 2023
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT05375890
Start Date
November 1 2019
End Date
September 28 2023
Last Update
March 13 2024
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Regional Clinical Hospital No.3
Chelyabinsk, Russia
2
Kazan State Medical University
Kazan', Russia
3
Private healthcare institution 'Clinical hospital 'RZD-Medicine'
Khabarovsk, Russia
4
Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency
Moscow, Russia